- Home
- / Our Newsletter
Stay Ahead in European HTA: Access Exclusive Insights
Sign up for our latest Tracker Reports to gain unparalleled insights into local health technology assessment processes and orphan drug developments in Germany.
Navigating the complex landscape of health technology assessments (HTAs) across Europe requires timely and accurate information. Our comprehensive reports are designed to equip healthcare professionals, market access teams, and regulatory affairs specialists with the knowledge needed to make informed decisions.
What You’ll Gain:
- German AMNOG Orphan Tracker Report: Delve into detailed analyses of orphan drug assessments under Germany’s AMNOG process, including recent benefit assessments and pricing negotiations. This is a bimonthly report.
Sign up to our Newsletter
Your partner in patient access.
At Kintiga, we do more than consult – we partner with you throughout the patient access journey. Our strategic global perspective and vast industry and local expertise combined with our cross-functional agility and AI-powered digital services, ensure your product reaches patients efficiently and sustainably.
